| Sep 16, 2025 |
Sep 18, 2025 |
Y-mAbs Therapeutics, Inc.
|
CHIEF BUSINESS OFFICER |
Sell |
37.5
|
-433,402
|
-100.00%
|
✗
|
$3.2M |
| Mar 7, 2025 |
Mar 11, 2025 |
Y-mAbs Therapeutics, Inc.
|
CHIEF BUSINESS OFFICER |
Sell |
22.5
|
-10,810
|
-3.17%
|
✗
|
$56.5K |
| Sep 13, 2024 |
Sep 17, 2024 |
Y-mAbs Therapeutics, Inc.
|
CHIEF BUSINESS OFFICER |
Sell |
17.5
|
-95,000
|
-24.91%
|
✗
|
$1.3M |
| Jun 10, 2024 |
Jun 11, 2024 |
Y-mAbs Therapeutics, Inc.
|
CHIEF BUSINESS OFFICER |
Sell |
20.0
|
-70,000
|
-15.51%
|
✗
|
$841.1K |
| May 21, 2024 |
May 23, 2024 |
Y-mAbs Therapeutics, Inc.
|
CHIEF BUSINESS OFFICER |
Sell |
20.0
|
-32,351
|
-6.69%
|
✗
|
$395.6K |
| Mar 5, 2024 |
Mar 7, 2024 |
Y-mAbs Therapeutics, Inc.
|
CHIEF BUSINESS OFFICER |
Sell |
32.5
|
-3,900
|
-0.80%
|
✗
|
$64.1K |
| Dec 13, 2023 |
Dec 15, 2023 |
Y-mAbs Therapeutics, Inc.
|
Chief Business Officer |
Sell |
17.5
|
-150,000
|
-26.52%
|
✗
|
$1M |
| Nov 20, 2023 |
Nov 22, 2023 |
Y-mAbs Therapeutics, Inc.
|
Chief Business Officer |
Sell |
20.0
|
-150,000
|
-20.96%
|
✗
|
$795.4K |
| Feb 7, 2022 |
Feb 9, 2022 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
17.5
|
-281,170
|
-29.40%
|
✗
|
$2M |
| Feb 3, 2022 |
Feb 7, 2022 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
17.5
|
-136,164
|
-12.47%
|
✗
|
$1.1M |
| Feb 1, 2022 |
Feb 3, 2022 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
47.5
|
-8,000
|
-0.73%
|
✓
|
$81.2K |
| Jan 24, 2022 |
Jan 26, 2022 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-88,055
|
-7.46%
|
✗
|
$936.4K |
| Jan 20, 2022 |
Jan 24, 2022 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
17.5
|
-183,085
|
-13.43%
|
✗
|
$2M |
| Jan 18, 2022 |
Jan 20, 2022 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
30.0
|
-77,814
|
-5.40%
|
✓
|
$853K |
| Dec 6, 2021 |
Dec 8, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-54,000
|
-3.63%
|
✗
|
$901.1K |
| Nov 29, 2021 |
Dec 1, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
35.0
|
-47,607
|
-3.10%
|
✓
|
$814.5K |
| Nov 23, 2021 |
Nov 26, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
20.0
|
-50,000
|
-3.15%
|
✗
|
$852.9K |
| Nov 16, 2021 |
Nov 18, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.26%
|
✓
|
$77.3K |
| Oct 29, 2021 |
Nov 1, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.26%
|
✓
|
$99.3K |
| Oct 15, 2021 |
Oct 19, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.26%
|
✓
|
$108.8K |
| Sep 30, 2021 |
Oct 4, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.26%
|
✓
|
$113.1K |
| Sep 15, 2021 |
Sep 17, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.26%
|
✓
|
$134.6K |
| Sep 2, 2021 |
Sep 7, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
17.5
|
-50,000
|
-3.22%
|
✗
|
$1.7M |
| Aug 13, 2021 |
Aug 17, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
42.5
|
-29,000
|
-1.83%
|
✓
|
$851K |
| Aug 3, 2021 |
Aug 5, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.25%
|
✓
|
$134.9K |
| Jul 20, 2021 |
Jul 21, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.25%
|
✓
|
$129.9K |
| Jul 7, 2021 |
Jul 8, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.25%
|
✓
|
$127.5K |
| Jun 30, 2021 |
Jul 2, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-4,000
|
-0.25%
|
✓
|
$135.4K |
| Jun 14, 2021 |
Jun 15, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
50.0
|
-4,000
|
-0.25%
|
✓
|
$143.2K |
| May 28, 2021 |
Jun 1, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
50.0
|
-4,000
|
-0.25%
|
✓
|
$147.8K |
| May 18, 2021 |
May 20, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
50.0
|
-4,000
|
-0.25%
|
✓
|
$136.3K |
| Apr 26, 2021 |
Apr 28, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
48.8
|
-7,000
|
-0.43%
|
✓
|
$195.7K |
| Apr 12, 2021 |
Apr 14, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-11,000
|
-0.68%
|
✓
|
$292.6K |
| Apr 1, 2021 |
Apr 5, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-15,000
|
-0.92%
|
✓
|
$453.9K |
| Mar 15, 2021 |
Mar 17, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-11,000
|
-0.67%
|
✓
|
$404.7K |
| Mar 1, 2021 |
Mar 3, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-15,000
|
-0.91%
|
✓
|
$532.6K |
| Feb 16, 2021 |
Feb 18, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-11,000
|
-0.67%
|
✓
|
$517.9K |
| Feb 1, 2021 |
Feb 3, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-11,000
|
-0.67%
|
✓
|
$461.8K |
| Jan 19, 2021 |
Jan 21, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-11,000
|
-0.67%
|
✓
|
$511.8K |
| Jan 5, 2021 |
Jan 7, 2021 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
45.0
|
-11,000
|
-0.66%
|
✓
|
$542.8K |
| Dec 28, 2020 |
Dec 30, 2020 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
46.3
|
-7,000
|
-0.42%
|
✓
|
$363.8K |
| Dec 16, 2020 |
Dec 17, 2020 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
46.3
|
-7,000
|
-0.42%
|
✓
|
$371.1K |
| Dec 14, 2020 |
Dec 16, 2020 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$211.5K |
| Dec 10, 2020 |
Dec 14, 2020 |
Y-mAbs Therapeutics, Inc.
|
Officer |
Sell |
16.3
|
-100,000
|
-5.71%
|
✗
|
$5.1M |
| Dec 1, 2020 |
Dec 2, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$205.7K |
| Nov 16, 2020 |
Nov 17, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$184.7K |
| Nov 2, 2020 |
Nov 5, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$174.8K |
| Oct 15, 2020 |
Oct 19, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$156.6K |
| Oct 1, 2020 |
Oct 2, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$155.5K |
| Sep 15, 2020 |
Sep 17, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$163.2K |
| Sep 10, 2020 |
Sep 15, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
17.5
|
-50,000
|
-2.90%
|
✗
|
$2M |
| Sep 1, 2020 |
Sep 2, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$166.4K |
| Aug 17, 2020 |
Aug 19, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.24%
|
✓
|
$161.4K |
| Aug 11, 2020 |
Aug 13, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
17.5
|
-50,000
|
-2.88%
|
✗
|
$2M |
| Aug 3, 2020 |
Aug 5, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.23%
|
✓
|
$146K |
| Jul 15, 2020 |
Jul 17, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.23%
|
✓
|
$160.2K |
| Jul 1, 2020 |
Jul 6, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.23%
|
✓
|
$168.2K |
| Jun 15, 2020 |
Jun 16, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.23%
|
✓
|
$173.8K |
| Jun 4, 2020 |
Jun 5, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.23%
|
✓
|
$166.4K |
| May 27, 2020 |
May 29, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
17.5
|
-50,000
|
-2.77%
|
✗
|
$2M |
| May 18, 2020 |
May 20, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.22%
|
✓
|
$158.6K |
| May 12, 2020 |
May 14, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
17.5
|
-50,000
|
-2.69%
|
✗
|
$2M |
| May 1, 2020 |
May 5, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$129.4K |
| Apr 13, 2020 |
Apr 15, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$117.7K |
| Mar 16, 2020 |
Mar 18, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$72K |
| Mar 2, 2020 |
Mar 4, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$116.7K |
| Feb 18, 2020 |
Feb 20, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$131.1K |
| Feb 10, 2020 |
Feb 11, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$132.1K |
| Jan 27, 2020 |
Jan 29, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$140.2K |
| Jan 13, 2020 |
Jan 15, 2020 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$123.6K |
| Dec 13, 2019 |
Dec 17, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
47.5
|
-12,000
|
-0.63%
|
✓
|
$126.2K |
| Dec 2, 2019 |
Dec 4, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$129.9K |
| Nov 18, 2019 |
Nov 19, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$113.7K |
| Nov 4, 2019 |
Nov 5, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$120.4K |
| Oct 21, 2019 |
Oct 22, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$110.4K |
| Oct 7, 2019 |
Oct 8, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$100.8K |
| Sep 16, 2019 |
Sep 17, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$122.4K |
| Sep 3, 2019 |
Sep 5, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$103.1K |
| Aug 19, 2019 |
Aug 20, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$110.8K |
| Aug 5, 2019 |
Aug 6, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$87.1K |
| Jul 22, 2019 |
Jul 23, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$90.2K |
| Jul 8, 2019 |
Jul 10, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$89.6K |
| Jun 24, 2019 |
Jun 25, 2019 |
Y-mAbs Therapeutics, Inc.
|
President |
Sell |
50.0
|
-4,000
|
-0.21%
|
✓
|
$87.1K |
| Jun 10, 2019 |
Jun 11, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.20%
|
✓
|
$91.2K |
| Jun 3, 2019 |
Jun 4, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
50.0
|
-4,000
|
-0.20%
|
✓
|
$80.1K |
| May 28, 2019 |
May 29, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
48.8
|
-6,000
|
-0.31%
|
✓
|
$121.3K |
| May 13, 2019 |
May 14, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
48.8
|
-6,000
|
-0.30%
|
✓
|
$123.6K |
| Apr 9, 2019 |
Apr 11, 2019 |
Y-mAbs Therapeutics, Inc.
|
Chair |
Sell |
16.3
|
-250,000
|
-11.26%
|
✗
|
$6.5M |